Treatment of vulvovaginal candidiasis using blue light therapy
Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial
NA · Centro de Atenção ao Assoalho Pélvico · NCT03075046
This study is testing if blue light therapy can help women with vulvovaginal candidiasis feel better and clear up the infection.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Centro de Atenção ao Assoalho Pélvico (other) |
| Locations | 1 site (Salvador, Ba) |
| Trial ID | NCT03075046 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a 405 nm blue light emitting diode in treating vulvovaginal candidiasis in women. It involves two groups: one with confirmed candidiasis and another with healthy genitourinary tracts. Participants undergo clinical evaluations and gynecological examinations before and after exposure to the blue light therapy. The study aims to assess both clinical and microbiological responses to this innovative treatment approach.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 65 with a clinical suspicion of vulvovaginal candidiasis or those with a healthy vaginal tract.
Not a fit: Patients with pacemakers, neoplasias, cognitive deficits, neurological or psychiatric diseases, pregnant women, or those who have used certain medications in the last 30 days may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive alternative for women suffering from recurrent vulvovaginal candidiasis.
How similar studies have performed: While the use of blue light therapy is a novel approach in this context, similar studies have shown promise in other antimicrobial applications.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women betwen 18 and 65 years old, with clinical suspect of vulvovaginal candidiasis and with health vaginal tract Exclusion Criteria: * Women with pacemakers, with diagnosis and / or suspicion of neoplasias, cognitive deficits, neurological and / or psychiatric diseases, pregnant women and women who have used oral antibiotics, fungicides, corticosteroids and vaginal creams in the last 30 days
Where this trial is running
Salvador, Ba
- Centro de Atenção ao Assoalho Pelvico — Salvador, Ba, Brazil (RECRUITING)
Study contacts
- Study coordinator: Patrícia Lordêlo, post doc
- Email: pvslordelo@hotmail.com
- Phone: 5571 988592400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Candidiasis, Vulvovaginal, Blue Light Emitting Diode, Women